Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Cancer Tumor Neoplasms
Study results
LPS GO28399 BRAF Final Results December 2020 Arabic
(PDF, 0.9 MB)
LPS GO28399 BRAF Final Results December 2020 Bosnian
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Croatian
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Dutch
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 English
(PDF, 1.4 MB)
LPS GO28399 BRAF Final Results December 2020 French
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 German
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Greek
(PDF, 0.7 MB)
LPS GO28399 BRAF Final Results December 2020 Hebrew
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Hungarian
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Italian
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Portuguese
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Romanian
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Russian
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Serbian
(PDF, 0.8 MB)
LPS GO28399 BRAF Final Results December 2020 Spanish
(PDF, 0.8 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com